The significance of non-human primates as preclinical models of human arthritic disease (Q38088311)

28 August 2017

The significance of non-human primates as preclinical models of human arthritic disease (English)

1 reference

28 August 2017

Michel Vierboom

1

1 reference

28 August 2017

Elia Breedveld

series ordinal

2

1 reference

28 August 2017

Ivanela Kondova

series ordinal

3

1 reference

28 August 2017

Bert A 't Hart

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Expert Opinion on Drug Discovery

28 August 2017

1 reference

28 August 2017

3

1 reference

28 August 2017

3

1 reference

28 August 2017

299-310

1 reference

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Immunogenicity of biopharmaceuticals in laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Safety and efficacy of therapeutic monoclonal antibodies in clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Drug discovery in jeopardy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Advances in sepsis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Animal models of rheumatoid arthritis and their relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

A spontaneous rheumatoid arthritis-like disease in MRL/l mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Animal models of arthritis caused by systemic alteration of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

The SCID mouse model: novel therapeutic targets - lessons from gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

New insights into the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Heterologous immunity provides a potent barrier to transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Tolerance: of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Major histocompatibility complex class II polymorphisms in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Collagen-induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Unparalleled complexity of the MHC class I region in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Modeling human arthritic diseases in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Preclinical models of arthritic disease in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Inflammatory cytokine responses in juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Asymptomatic synovitis precedes clinically manifest arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Acquired resistance to type II collagen-induced arthritis in rhesus monkeys is reflected by a T cell low-responsiveness to the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Preclinical models of multiple sclerosis in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

Evaluating the validity of animal models for research into therapies for immune-based disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

The price of innovation: new estimates of drug development costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.3.299

21 January 2018

Identifiers

DOI

10.1517/17460441.3.3.299

1 reference

28 August 2017

1 reference